Substituted pyridine derivatives useful as GSK-3 inhibitors
US9809573B2 · kind B2 · utility
0Cited by
3References
3Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Nov 3, 2014 |
| Grant date | Nov 7, 2017 |
| Priority date | — |
| Expiry date | Nov 3, 2034 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D513/04
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
The disclosure generally relates to compounds of formula I, including their salts, as well as compositions and methods of using the compounds. The compounds are ligands, antagonists of the NR2B receptor and may be useful for the treatment of various disorders of the central nervous system.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.